AI-powered healthtech and medical imaging diagnostics platform.
Intixel is a healthtech company headquartered in Cairo, Egypt, leveraging cutting-edge AI and blockchain technology to revolutionize medical imaging diagnostics. Its flagship products, such as AIRABreast and AIRAChest, empower radiologists with advanced tools for tumor and abnormality detection in scans, serving as a second opinion for medical professionals.
Founded in 2018 by a visionary team led by Mustafa Elattar, Intixel collaborates with hospitals, clinics, and oncology centers, addressing healthcare needs in regions with high patient volumes and limited physician capacity. The company’s solutions seamlessly integrate with hospital PACS systems to automate diagnosis and workflow, improving efficiency and accuracy.
Over time, Intixel has partnered with organizations like Villgro and received seed funding from Flat6Labs Cairo, enabling further innovation and expansion. Its multi-disciplinary team includes experts in AI, computer science, and medical imaging, with a mission to drive digital transformation in healthcare and beyond throughout North Africa.
Flat6Labs Cairo
Seed funding - Spring 2021
Villgro
Grant funding and technical support
Mustafa Elattar
Founder and CTO with a PhD in Biomedical Engineering and Physics from University of Amsterdam. Associate Professor at Nile University.
Dr. Thanaa Mohannad
Chief Medical Officer and CEO with expertise in radiology and clinical nutrition. Entrepreneur and medical professional.
Mahmoud Higazy
Software Developer at Intixel, contributing to the development of AI-powered healthcare solutions.
Mina Essam
AI Team Lead with a Master's in Computer Science, leading artificial intelligence development efforts at Intixel.